Infliximab in inflammatory bowel disease: attention to adverse events

Uyanikoglu, A.; Ermis, F.; Akyuz, FİLİZ; Pinarbasi, B.; Baran, B.; Aydogan, T.; Demir, K.; Besisik, SELMAN; Kaymakoglu, SABAHATTİN

Infliximab in inflammatory bowel disease: attention to adverse events

Uyanikoglu A., Ermis F., Akyuz F., Pinarbasi B., Baran B., Aydogan T., ...More

EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, vol.18, no.16, pp.2337-2342, 2014 (SCI-Expanded, Scopus)

Publication Type: Article / Article
Volume: 18 Issue: 16
Publication Date: 2014
Journal Name: EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.2337-2342
Istanbul University Affiliated: Yes

Abstract

OBJECTIVE: To assess the efficacy and adverse effects of infliximab in patients with Crohn's disease and ulcerative colitis who are resistant to conventional therapy or having fistulising type Crohn's disease.